Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2025Scientific ReportsOpen Access

Targeted design, synthesis, molecular dynamics, ADME and in –vitro anticancer assessment of oxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids as potential BRAFV600E inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAnkit Kumar SinghAKAdarsh KumarHSHarshwardhan Singh

Discussion

Loading...

Member takes

Overview

This study demonstrates significant anticancer activity and BRAF kinase inhibition in synthesized compounds, highlighting their potential as drug leads.

Key Points

  • Compound S4 showed strong inhibition of the BRAFV600E kinase at 91%, comparable to the drug sorafenib.
  • All synthesized derivatives were characterized using NMR and mass spectrometry, followed by tests for anti-proliferative activity in cancer models.
  • Molecular dynamics simulations were conducted on selected compounds to assess binding stability within the BRAFV600E active site.
  • These findings suggest that oxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids could be developed as effective BRAFV600E inhibitors.

Cite This Study

Singh et al. (2025) studied this question.

synapsesocial.com/papers/68e9435d2d5336d28fb2897bhttps://doi.org/10.1038/s41598-025-18835-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Design, Synthesis, Molecular Docking, <scp>ADME</scp>‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential <scp>BRAF<sup>V600E</sup></scp><sup>/<scp>WT</scp></sup> Inhibitors2025 · 1 citations
  2. 2Targeting Cancer with New Morpholine-Benzimidazole-Oxadiazole Derivatives: Synthesis, Biological Evaluation, and Computational Insights2025 · 6 citations
  3. 3Design, Synthesis, and Bioactivity Assessment of Modified Vemurafenib Analog2025
  4. 4Design, synthesis, and <i>in silico</i> studies of new benzofuran–pyrazole hybrids as multi-kinase inhibitors with potential antiproliferative activity2025
  5. 5Mutation-specific structural changes in BRAF: understanding dimerization and drug binding for targeted therapy.2025